Polymorphism of the rs1800896 IL10 promoter gene protects children from post-bronchiolitis asthma

Petri Koponen1, Kirsi Nuolivirta, Miia Virta

  • 1Pediatric Research Centre, Tampere University and University Hospital, Tampere, Finland.

Pediatric Pulmonology
|October 30, 2013
PubMed

Insights

Infant bronchiolitis increases childhood asthma risk. A specific IL10 gene variant (rs1800896) is linked to this increased risk, suggesting a genetic predisposition to post-bronchiolitic asthma.

Area of Science:

  • Pediatric Pulmonology
  • Immunogenetics
  • Asthma Research

Background:

  • Viral bronchiolitis is a common cause of infant hospitalization and a risk factor for childhood asthma.
  • The underlying mechanisms connecting bronchiolitis to asthma development remain incompletely understood.
  • Previous studies linked cytokine gene variations to asthma, but not specifically to post-bronchiolitic asthma development.

Purpose of the Study:

  • To investigate the association between specific cytokine gene polymorphisms and the risk of developing asthma after early infancy bronchiolitis.
  • To test the hypothesis that cytokine gene variants promoting Th2 cell responses increase asthma risk in preschool children previously hospitalized for bronchiolitis.
  • To focus on the IL10 rs1800896 polymorphism due to IL-10's role in immune tolerance and its association with Th2-type immunity.

Main Methods:

  • A follow-up study involving 135 preschool-aged children hospitalized for bronchiolitis between 0-6 months of age.
  • Genotyping for IL10 rs1800896, IFNG rs2430561, and IL18 rs1872387 polymorphisms.
  • Parental interviews to collect data on asthma and allergy diagnoses from infancy to preschool age (mean 6.4 years).
  • Statistical analysis, including logistic regression adjusted for gender, age, and atopy.

Main Results:

  • Asthma was diagnosed in 12.6% of the children by preschool age.
  • The IL10 rs1800896 single nucleotide polymorphism (SNP) showed a significant association with asthma development (P=0.04).
  • Carriage of the A allele at IL10 rs1800896 was identified as a significant risk factor for preschool asthma after adjusting for covariates.
  • No significant associations were found for IFNG rs2430561 or IL18 rs1872387 polymorphisms with asthma or allergy.

Conclusions:

  • The IL10 rs1800896 polymorphism is significantly associated with the development of preschool asthma following severe lower respiratory tract infections in early infancy.
  • This finding suggests a genetic predisposition, specifically related to IL-10 immune regulation, plays a role in the link between infant bronchiolitis and later asthma development.
  • Further research into cytokine gene variants could elucidate mechanisms and identify at-risk infants for targeted interventions.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
360
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
31.3K